Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00911014 · ClinicalTrials.gov registry record
Access to Healthcare, Patient Comprehension and Future Plans of Women Undergoing Surgery for a Vesicovaginal Fistula in Niamey, Niger
A clinical trial, sponsored by Ascher-Walsh, Charles, M.D..
- Completed
- Registry status
- 58
- Enrollment target
NCT00911014: Completed study, sponsored by Ascher-Walsh, Charles, M.D..
NCT00911014 is a clinical trial that has completed, run by Ascher-Walsh, Charles, M.D.. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00911014 has completed, sponsored by Ascher-Walsh, Charles, M.D..
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
Study Summary
Evaluate access to healthcare, comprehension of pre-operative counseling and post-operative goals of women treated for vesicovaginal fistula in Niger through use of a questionnaire.
Interventions
- OTHER Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2005-09 |
| Est. Completion | 2006-01 |
What the finished NCT00911014 record still lists
NCT00911014 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT00911014 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00911014 about?
NCT00911014 is a clinical study titled "Access to Healthcare, Patient Comprehension and Future Plans of Women Undergoing Surgery for a Vesicovaginal Fistula in Niamey, Niger". Evaluate access to healthcare, comprehension of pre-operative counseling and post-operative goals of women treated for vesicovaginal fistula in Niger through use of a questionnaire.
What is the current status of trial NCT00911014?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2005-09. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00911014?
The interventions under investigation include: Questionnaire (OTHER).
Who is sponsoring clinical trial NCT00911014?
This trial is sponsored by Ascher-Walsh, Charles, M.D., which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia